Chapter 4: Hemostasis and Related Disorders Flashcards
What is the first step of primary hemostasis?
Transient vasoconstriction of damaged vessel
What mediates initial vasoconstriction of vessel?
neural stimulation and ENDOTHELIN
Where does vWF come from?
Platelets and endothelial cells
Weibel-Palade bodies in endothelial cells
Alpha granules of Platelets
Weibel-Palade bodies have P-selectin speedbumps and vWF
Describe what causes platelet degranulation…
adhesion of platelets to vWF cause shape change and subsequent degranulation with release of mediators.
ADP is released from dense granules which promotes exposure of GPIIb/IIIa receptors on platelets which is important for AGGREGATION. Also causes TXA2 to be synthesized by COX which also helps aggregation
Where is ADP stored in platelet?
dense granules
What is aggregation? how is it mediated?
Platelet aggregation is mediated with GPIIb/IIIa receptors that were upregulated in response to ADP release from platelet dense granules
Also, Thromboxane A2, synthesized by platelet cyclooxygenase and released, which promotes aggregation
What is adhesion? how is it mediated?
Platelet adhesion is mediated with vWF on basement membrane and GPIb on platelets
What is a generally true statement about QUANTITATIVE platelet reductions as opposed to QUALITATITVE platelet reductions?
quantitative reductions result in petechiae
What is a bone marrow biopsy used to assess?
Megakaryocytes, which produce platelets
Immune Thrombocytopenia caused by…
Antibodies binding to GPIIb/IIIa receptors on platelets. These antibodies are created in the spleen and the Ab-platelet complex is also consumed by macrophages in the spleen.
petechiae presents in child weeks after a viral infection or immunization
Immune Thrombocytopenia, is usually self-limited.
Antibodies bind to GPIIb/IIIa receptors on platelets
ITP is A/W
SLE, Lupus. Since in Systemic lupus they can have Antibodies to almost anything, RBC’s, WBC’s or…PLATELETS
Women with chronic ITP can have what complication…
During pregnancy, since IgG can cross membrane, Infant can have transient ITP until IgG’s are consumed.
ITP lab findings
low platelet(<50,000)
PT and PTT normal
Increase in Megakaryocytes to compensate for decrease in platelets
One treatment for ITP is IVIG. Describe mechanism…
When you give IVIG, you throw in so many extra platelets that your hoping the spleen will want to eat up these IgG’s instead of the one’s that are attached to your platelets to cause a temporary increase in platelets. This effect is SHORT lived
Splenectomy does what in context of ITP
eliminates the PRIMARY SOURCE of antibody AND the site of platelet destruction
Microangiopathic Hemolytic Anemia
Microthrombi in vessels shear RBC’s into schistocytes resulting in hemolytic anemia
Thrombotic Thrombocytopenic Perpura is A/W what gene product?
ADAMTS13 (von Willebrand factor-cleaving protease)
TTP Pathophys
ADAMTS13 normally cleaves vWF multimers. ADAMTS13 is reduced in TTP and thus the multimers persist and cause abnormal platelet adhesion resulting in microthrombi
Common cause of TTP
Decreased ADAMTS13(von Willebrand factor-cleaving protease) is normally due to an ACQUIRED antibody that destroys ADAMTS13, commonly seen in adult women
HUS A/W
Enterotoxigenic E.Coli(O157:H7) produces verotoxin that damages endothelial cells, particularly in kidney/brain, and that creates microthrombi which shear red blood cells
undercooked beef, possibly in children
ETEC O157:H7
Most common clinical findings in HUS
Renal insufficiency - thrombi in vessels of kidney
Most common clinical findings in TTP
CNS abnormalities - thrombi in vessels of CNS
Lab findings in TTP/HUS
Thrombocytopenia with INCREASED bleed time
NORMAL PT/PTT
Anemia with Schistocytes
Increased megakaryoctes as a compensatory response(hyperplasia)
Bernard-Soulier syndrome
genetic GPIB deficiency; platelet ADHESION impaired
blood smear shows thrombocytopenia with enlarged platelets.
enlarged because they are slightly more immature
Glanzmann’s Thrombasthenia
genetic GPIIB/IIIA deficiency; platelet AGGREGATION is impaired
Aspirin MOA
blocks COX irreversibly. Blocks production of TXA2 which impairs AGGREGATION. Important chemoattractant for other platelets
Uremia. How does it affect clot formation?
Uremia is a buildup of nitrogenous waste products due to poor kidney function - both adhesion and aggregation are impaired
what happens when fibrin is cross linked?
stable clot formed…
What three things are required to activate factors of coagulation cascade?
- ) Phospholipid surface - provided by platelets
- ) Activating substance - Tissue thromboplastin/Tissue Factor activates Factor VII or Subendothelial collagen activates factor XII.
- ) Calcium
defective Secondary hemostasis clinical symptoms
deep bleeding, rebleeding
PT
extrinsic